SpIntellx is a computational pathology company developing novel AI tools based on spatial analytics. Founded by Chakra Chennubhotla, Jeffrey Fine, Lansing Taylor, and Michael Becich in 2017, SpIntellx is backed by investors that include Innovation Works and Newlin Investment Company and is headquartered in Pittsburgh.